Get started
Author

Maria Aslani Gkotzamanidou

Observed names: M Gkotzamanidou, M. Gkotzamanidou, Maria Aslani-Gkotzamanidou, Maria Gkotzamanidou, Μαρία Γκοτζαμανίδου
Observed institutions: Harvard University, National and Kapodistrian University of Athens, VA Boston Healthcare System, Hellenic Air Force, Hellenic Airforce General Hospital, Alexandra Hospital, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, University General Hospital Attikon, Hippocration General Hospital
ORCID: 0000-0003-0756-7176
Observed ORCID: 0000-0003-0756-7176
OpenAlex ID: A5044318093
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post‐bortezomib monotherapy
2011 · Evangelos Terpos, Dimitrios Christoulas, et al. · International Journal of Cancer · 186
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
2012 · M A Dimopoulos, M Roussou, et al. · Leukemia · 162
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
2012 · E Kastritis, E Terpos, et al. · Leukemia · 161
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
2010 · M A Dimopoulos, E Kastritis, et al. · Leukemia · 120
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy
2012 · E. Terpos, E. Kastritis, et al. · Annals of Oncology · 108
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients
2012 · Lia A. Moulopoulos, Meletios A. Dimopoulos, et al. · American Journal of Hematology · 100
PDF
Dickkopf-1: a suitable target for the management of myeloma bone disease
2009 · Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, et al. · Expert Opinion on Therapeutic Targets · 69
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents
2010 · L A Moulopoulos, M A Dimopoulos, et al. · Leukemia · 67
High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
2012 · E. Voskaridou, D. Christoulas, et al. · Hormone and Metabolic Research · 61
Increased Serum Lactate Dehydrongenase Should Be Included Among the Variables That Define Very-High-Risk Multiple Myeloma
2011 · Maria Gkotzamanidou, Efstathios Kastritis, et al. · Clinical Lymphoma Myeloma & Leukemia · 46
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
2021 · A. Psyrri, M. Gkotzamanidou, et al. · ESMO Open · 44
PDF
The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: Final results on 205 patients of the Greek myeloma study group
2013 · Evangelos Terpos, Dimitrios Christoulas, et al. · American Journal of Hematology · 44
PDF
Circulating angiopoietin‐1 to angiopoietin‐2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents
2011 · Evangelos Terpos, Konstantinos Anargyrou, et al. · International Journal of Cancer · 41
PDF
DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
2016 · Maria Gkotzamanidou, Evangelos Terpos, et al. · Blood · 40
PDF
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT
2013 · E Terpos, D Christoulas, et al. · Leukemia · 40
Peripheral T-cell lymphoma: The role of hematopoietic stem cell transplantation
2013 · Maria Gkotzamanidou, Christos A. Papadimitriou · Critical Reviews in Oncology/Hematology · 34
Sclerostin: a possible target for the management of cancer-induced bone disease
2012 · Maria Gkotzamanidou, Meletios A Dimopoulos, et al. · Expert Opinion on Therapeutic Targets · 34
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens
2011 · Evangelos Eleftherakis-Papapiakovou, Esftathios Kastritis, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 33
Response to bortezomib of a patient with scleromyxedema refractory to other therapies
2011 · Magdalini Migkou, Maria Gkotzamanidou, et al. · Leukemia Research · 31
Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
2021 · Panagiota Economopoulou, Maria Anastasiou, et al. · Cancers · 29
Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
2020 · Panagiota Economopoulou, Athina Kladi-Skandali, et al. · ESMO Open · 29
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
2023 · Myrto Moutafi, Georgia-Angeliki Koliou, et al. · Cancer Research Communications · 27
PDF
RETRACTED ARTICLE: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
2014 · M Gkotzamanidou, P P Sfikakis, et al. · British Journal of Cancer · 27
PDF
Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesis
2013 · M Gkotzamanidou, E Terpos, et al. · Leukemia · 26
Transcription factor-pathway coexpression analysis reveals cooperation between SP1 and ESR1 on dysregulating cell cycle arrest in non-hyperdiploid multiple myeloma
2013 · X Wang, Z Yan, et al. · Leukemia · 25
Works count: 151
Citation count: 1,860
H-index: 25
I10-index: 34
Year
Topic
Type